Back to IRWDView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Functional Constipation in Children Ages 6-17 Years
View Full LandscapeDrug Information
Target Indication
Functional Constipation in Children Ages 6-17 Years
Clinical Trial
NCT02559570Last updated: 9/23/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Linaclotide 145 microgramsPhase 3
Opioid-Induced Constipation
Linaclotide 290 microgramsPhase 3
Irritable Bowel Syndrome Characterized by Constipation
IW-3718Phase 3
Gastroesophageal Reflux Disease (GERD)
LinaclotidePhase 3
Irritable Bowel Syndrome With Constipation
Linaclotide AcetatePhase 2
Irritable Bowel Syndrome With Constipation
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts